5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.
作者信息
Bremer K
机构信息
Augusta-Kranken-Anstalt Bochum, Federal Republic of Germany.
出版信息
J Cancer Res Clin Oncol. 1991;117(1):85-7. doi: 10.1007/BF01613203.
Abstract
摘要
相似文献
1
5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.
J Cancer Res Clin Oncol. 1991;117(1):85-7. doi: 10.1007/BF01613203.
2
Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.
Cochrane Database Syst Rev. 2016 Feb 2;2(2):CD007786. doi: 10.1002/14651858.CD007786.pub3.
3
Blueprint for the control of radiation-induced nausea and vomiting. Discussion.
Acta Oncol. 2004 Sep;43 Suppl 15:23-4. doi: 10.1080/11001700410016170.
4
Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
Cochrane Database Syst Rev. 2010 Sep 8(9):CD007786. doi: 10.1002/14651858.CD007786.pub2.
5
Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.
J Natl Cancer Inst. 2012 Sep 5;104(17):1280-92. doi: 10.1093/jnci/djs335. Epub 2012 Aug 21.
6
Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):408-17. doi: 10.1016/j.ijrobp.2010.08.060. Epub 2010 Nov 13.
7
Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting.
Tumori. 2008 Jul-Aug;94(4):447-52. doi: 10.1177/030089160809400401.
8
Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
J Clin Oncol. 2011 Nov 1;29(31):4189-98. doi: 10.1200/JCO.2010.34.4614. Epub 2011 Sep 26.
9
Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
Ann Palliat Med. 2018 Apr;7(2):221-233. doi: 10.21037/apm.2018.03.09.
10
Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
Cancer Chemother Pharmacol. 2005 Sep;56(3):231-8. doi: 10.1007/s00280-005-1033-0. Epub 2005 Apr 19.
引用本文的文献
1
A systematic review of methodologies, endpoints, and outcome measures in randomized trials of radiation therapy-induced nausea and vomiting.
Support Care Cancer. 2017 Jun;25(6):2019-2033. doi: 10.1007/s00520-017-3685-9. Epub 2017 Mar 31.
2
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.
Thorax. 1999 Feb;54(2):161-8. doi: 10.1136/thx.54.2.161.
本文引用的文献
1
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
N Engl J Med. 1981 Oct 15;305(16):905-9. doi: 10.1056/NEJM198110153051601.
2
On the receiving end--patient perception of the side-effects of cancer chemotherapy.
Eur J Cancer Clin Oncol. 1983 Feb;19(2):203-8. doi: 10.1016/0277-5379(83)90418-2.
3
Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs.
Eur J Pharmacol. 1970;12(3):332-41. doi: 10.1016/0014-2999(70)90085-3.
4
Pharmacological analysis of the effects of metoclopramide on the guinea-pig ileum in vitro.
Arch Int Pharmacodyn Ther. 1973 Aug;204(2):293-305.
5
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.
J Clin Oncol. 1985 Oct;3(10):1379-84. doi: 10.1200/JCO.1985.3.10.1379.
6
Extrapyramidal reactions with metoclopramide.
Br Med J (Clin Res Ed). 1985 Oct 5;291(6500):930-2. doi: 10.1136/bmj.291.6500.930.
7
Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
Br Med J (Clin Res Ed). 1986 Nov 22;293(6558):1334-7. doi: 10.1136/bmj.293.6558.1334.
8
Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism.
Br J Pharmacol. 1986 Jul;88(3):497-9. doi: 10.1111/j.1476-5381.1986.tb10228.x.
9
Ondansetron with and without dexamethasone to treat chemotherapy-induced emesis.
Lancet. 1989 Jun 10;1(8650):1323. doi: 10.1016/s0140-6736(89)92711-6.
10
Proceedings of the Ondansetron Symposium. London, 30 June 1989.
Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S1-93.
Zotero 插件